Cargando…
Does allergen immunotherapy impact the susceptibility and severity of COVID‐19?
Autores principales: | Wang, Yin, Chen, Huan, Dong, Xiang, Chen, Hao, Liang, Hui‐ling, Yang, Ya‐qi, Chen, Yan‐dan, Zhu, Rong‐fei, Gao, Ya‐dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10123383/ https://www.ncbi.nlm.nih.gov/pubmed/37186424 http://dx.doi.org/10.1002/clt2.12247 |
Ejemplares similares
-
Allergen specificity is relevant for immunotherapy prescription in polysensitised children
por: Ciprandi, Giorgio, et al.
Publicado: (2012) -
Tablet allergen immunotherapy (TAIT) requires tight management
por: Ciprandi, Giorgio
Publicado: (2021) -
Dropouts From Sublingual Immunotherapy and the Transition to Subcutaneous Immunotherapy in House Dust Mite-Sensitized Allergic Rhinitis Patients
por: Chen, Huan, et al.
Publicado: (2022) -
Treatment of Severe Atopic Dermatitis with a Combination of Subcutaneous Allergen Immunotherapy and Cyclosporin
por: Nahm, Dong-Ho, et al.
Publicado: (2012) -
Allergen immunotherapy
por: Crisafulli, Giuseppe, et al.
Publicado: (2014)